Both in Pharmaceuticals
Xencor vs Septerna
Over the past year XNCR returned +116.5% and SEPN returned +115.6%; their daily moves had a correlation of 0.32.
XNCR +116.5% SEPN +115.6%Growth of $1, one year, split-adjusted
| Metric | XNCR | SEPN |
|---|---|---|
| Price | $25.00 | $39.13 |
| Market cap | $1.86B | $1.83B |
| Today | −2.34% | −1.53% |
| 1 month | −4.1% | +0.6% |
| 6 months | +120.3% | +67.9% |
| Year to date | +63.3% | +40.4% |
| 1 year | +116.1% | +124.2% |
| Revenue growth (YoY) | +17.5% | +22375.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −42.4% | −48.7% |
| P/E (TTM) | — | — |
| Price / sales | 17.7× | 18.5× |
| Net cash | $351.6M | $372.3M |
| Dividend yield | — | — |
| Volatility (60d) | 69.1% | 67.2% |
| Short % of float | 21.8% | 9.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).